⌘K

Home/Filings/4/0001493152-20-003033

4//SEC Filing

Arrow Alexander K. 4

Accession 0001493152-20-003033

CIK 0001022899other

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 8:15 PM ET

Size

5.6 KB

Accession

0001493152-20-003033

Insider Transaction Report

Form 4

Period: 2020-02-21

Protagenic Therapeutics, Inc.\newPTIX

Arrow Alexander K.

Chief Financial Officer

Transactions

Award
PTIX Common stock Options
2020-02-21+307,497→ 307,497 total
Exercise: $1.75From: 2023-02-21Exp: 2030-02-21→ PTIX Common Stock, Par Value $0.0001 (307,497 underlying)

Footnotes (1)

[F1]As this was an option grant, there was no cost to the recipient.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Protagenic Therapeutics, Inc.\new

CIK 0001022899

Entity typeother

Related Parties

1

filerCIK 0001497166

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 8:15 PM ET
Size: 5.6 KB

View on SEC.gov